Stairlifts Market: Foresees Skyrocketing Growth in the Coming Years Alveolar Rhabdomyosarcoma Treatment Market

Alveolar Rhabdomyosarcoma Treatment Market
- Global Industry Insights, Trends, Outlook, and
Opportunity Analysis, 2018-2026
Alveolar rhabdomyosarcoma (ARMS) is a type of soft tissue sarcoma that originates from the
connective tissues of the body such as bone, muscle, cartilage, and ligaments. According to the
survey by Children’s Oncology Group, 2011, alveolar rhabdomyosarcoma makes up about 25-40% of
RMS. ARMS is mostly detected in adolescents and often occurs on the arms, legs, chest, and
stomach. The exact cause of alveolar rhabdomyosarcoma is unknown, however it is associated with
other conditions such as Neurofibromatosis type 1, Beckwith-Wiedemann syndrome, Li-Fraumeni
syndrome, Cardio-facio-cutaneous syndrome, and Costello syndrome. The methods for diagnosis of
ARMS include examination such as X-ray imaging, CT scan, MRI, bone scan, ultrasound, PET scan,
and a biopsy, in order to plan a suitable treatment for the condition. ARMS is a type of high-grade
tumor meaning it cells are characterized by rapid growth and faster progression.
Request Sample Copy of Research Report:
https://www.coherentmarketinsights.com/insight/request-sample/1552
Alveolar Rhabdomyosarcoma Treatment Market: Regional Dynamics
Regional segmentation of the global alveolar rhabdomyosarcoma treatment market by Coherent
Market Insights comprises North America, Latin America, Europe, Asia Pacifc, Middle East, and
Africa. North America is expected to hold a dominant position in the global alveolar
rhabdomyosarcoma treatment market over the forecast period, owing to rising number of
initiatives undertaken by organizations in the region to develop potential therapies, increasing
research and development, and adoption of advanced radiation therapies. Organizations in the
region have initiated the frst molecular targeted drug in a clinical trial in 2011, for childhood
muscle cancer at the Doernbecher Children's Hospital and Children Oncology Group (COG) sites.
Also, St. Baldrick’s Foundation works in collaboration with pediatric oncologists and funds
supportive cancer research to develop promising research to positively impact treatment of
children with cancer. Moreover, other organization such as the National Cancer Institute, Scott
Carter Foundation, Alex's Lemonade Stand Foundation, and the Hyundai Hope on Wheels
Program have funded various studies, in order to explore highly potential therapeutic options.
The alveolar rhabdomyosarcoma treatment market in Asia Pacifc is expected to witness high